DaVita
DVA
#2385
Rank
A$11.22 B
Marketcap
A$157.01
Share price
1.96%
Change (1 day)
-45.25%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.54

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.27. In 2024 the company made an earnings per share (EPS) of A$15.84 an increase over its 2023 EPS that were of A$10.93.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.54-1.88%
2024A$15.8444.94%
2023A$10.9327.26%
2022A$8.59-35.56%
2021A$13.3344.1%
2020A$9.2519.7%
2019A$7.73540.48%
2018A$1.21-76.07%
2017A$5.04-19.31%
2016A$6.25242.52%
2015A$1.82-62.87%
2014A$4.9113.43%
2013A$4.338.45%
2012A$3.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$30.66 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.72 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$21.11 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.73-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA